Mitraclip treatment for patients with functional mitral regurgitation.

Trial ID:
Matthew J Price, M.D.
The usual treatment for mitral regurgitation (MR) is an open heart procedure to repair the leaflets of the valve by sewing them together. Additional measures may also be used, such as placing a ring around the mitral valve. The MitraClip will have the same function as sewing the leaflets of the valve together, but without the need for open-heart surgery. The MitraClip procedure is used to treat only certain kinds of MR, where surgery cannot be done. Follow-up will be frequent immediately after the procedure and follow-up visits will continue at least every 6 months for 5 years.

Inclusion Criteria

  • Have severe Mitral regurgitation
  • Have tried all other reasonable options for treatment
  • Have had at least one hospitalization for heart failure in the past 12 months
  • Meet all other eligibility criteria

Exclusion Criteria

  • Have Chronic Obstructive Pulmonary Disease (COPD)
  • Have Transcatheter aortic valve replacement (TAVR) within the past 30 days
  • Have Life expectancy of more than 12 months due to non-cardiac conditions.
  • Have Status 1 heart transplant
  • Have a Prior mitral valve leaflet surgery

Additional Info

  • All eligible patients who enroll in this study will receive the Mitraclip procedure to treat their mitral regurgitation.

Contact Info:

  • Heather Catchpole
  • 858-824-4248